Health Policy Watch | COVID-19 drops out of world’s top 10 causes of death for first time since pandemic began - European AIDS Treatment Group
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Health Policy Watch news storyCOVID-19 dropped out of the world’s 10 leading causes of death in 2023 for the first time since the pandemic began in 2020, and only two years after it topped the list, according to new World Health Organization estimates released Friday (2 October). The virus directly killed an estimated 0.9 million people in 2023, ranking 14th, as global life expectancy climbed back to near its pre-pandemic level. WHO declared an end to COVID-19 as a global health emergency in May that year. Revised figures now rank COVID-19 as the world’s leading cause of death in 2021, with 9.4 million direct deaths. WHO’s earlier estimates had placed it second that year. Together with 5.3 million deaths in 2020, the new figures put the virus’s direct toll in the first two years of the pandemic at 14.7 million. Read the full news story here.
This article is an excerpt. To read the full content, visit the original source. European AIDS Treatment Group
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!